5-Chloro-3-fluoropicolinonitrile, 97.0%, 1g

Methyl 3-formylbenzoate, 95.0%, 500g

2-Methyl-3-nitrophenol, 98.0%, 25g

1,4-Thioxane, >97.50%, 5g

7-(tert-Butoxycarbonyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-3-carboxylic acid, 98%, 1g

8-Acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 250mg

2-Amino-6-phenyl-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carboxylic acid methyl ester, 95.0%, 10g

3-Fluorobenzonitrile, 98.0%, 500g

5-(4-Carbamoylpiperazin-1-yl)-5-oxopentanoic acid, 1g

3,3a,4,5,6,6a-hexahydrocyclopenta[d][1,3]oxazol-2-one, 97%, 1g

Polyethylene Glycol Distearate (n=approx. 10)25g

TOLAZAMIDE, 98%, 100mg

Objectif corrigé à l'infini Plan PLi 4x/0.10 IOS